NeuroPace Files with FDA for Epilepsy Device
NeuroPace, a company focused on implantable devices for the treatment of brain disorders, announced Thursday that it has filed for Pre-Market Approval with the U.S. Food and Drug Administration for its investigational device for epilepsy patients.